Turning Reciprocal Feedback Regulation into Combination Therapy

Slides:



Advertisements
Similar presentations
Aurora Kinases and Protein Phosphatase 1 Mediate Chromosome Congression through Regulation of CENP-E Yumi Kim, Andrew J. Holland, Weijie Lan, Don W. Cleveland.
Advertisements

Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
The Kinase-Independent, Second Life of CDK6 in Transcription
Charles Swanton, Julian Downward  Cancer Cell 
Of Worms and Men: HLH-30 and TFEB Regulate Tolerance to Infection
Volume 19, Issue 5, Pages (May 2011)
Connecting COX-2 and Wnt in cancer
Volume 1, Issue 1, Pages (June 2007)
IRS-1: Auditing the effectiveness of mTOR inhibitors
Wild-Type RAS: Keeping Mutant RAS in CHK
Mutant p53 gain of function: The NF-Y connection
Volume 14, Issue 2, Pages (August 2008)
Volume 11, Issue 4, Pages (April 2007)
The Akt-mTOR tango and its relevance to cancer
RAS unplugged: Negative feedback and oncogene-induced senescence
Kinase inhibitors: Vice becomes virtue
CALming Down T Cell Acute Leukemia
Taking T Cell Priming Down a Notch: Signaling through Notch Receptors Enhances T Cell Sensitivity to Antigen  Timothy J. Thauland, Manish J. Butte  Immunity 
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Volume 26, Issue 1, Pages 1-2 (July 2014)
Suppressing NFAT Increases VEGF Signaling in Hemangiomas
T Helper 17 Cells Get the NOD
Polycomb Regulates NF-κB Signaling in Cancer through miRNA
Volume 13, Issue 1, Pages 1-2 (January 2008)
Methed-Up FOXOs Can't In-Akt-ivate
A Radical Role for p38 MAPK in Tumor Initiation
CALming Down T Cell Acute Leukemia
Volume 19, Issue 6, Pages (June 2011)
PICS-ure This: Prosenescence Therapy?
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
PTEN Enters the Nuclear Age
Apoptosis-targeted therapies for cancer
Volume 22, Issue 6, Pages (December 2012)
Volume 46, Issue 5, Pages (June 2012)
Taru Muranen, Funda Meric-Bernstam, Gordon B. Mills  Cancer Cell 
Eukaryotic Transcription Activation: Right on Target
Characterizing the Killer Colorectal Carcinomas
IRS-1: Auditing the effectiveness of mTOR inhibitors
Theodoros Karantanos, Timothy C. Thompson  Cancer Cell 
The RAS/MAPK Axis Gets Stressed Out
A new mouse model of pancreatic cancer: PTEN gets its Akt together
A New FOXO Pathway Required for Leukemogenesis
NOTCH and PI3K-AKT Pathways Intertwined
AKT/PKB Signaling: Navigating Downstream
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Proteins in Plant Brassinosteroid Signaling
Apoptosis-targeted therapies for cancer
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
William G. Nelson, Michael C. Haffner, Srinivasan Yegnasubramanian 
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Smoothing Out Drug Resistance
A Missing Link in Genotype-Directed Cancer Therapy
A common pathway for genetic events leading to pheochromocytoma
Tailor Made Protein Synthesis for HSCs
Role reversal: Brain insulin and liver STAT3
Volume 10, Issue 3, Pages (September 2006)
All Roads Lead to the Ribosome
The TRIP from ULF to ARF Cancer Cell
There's a Time and a Place for MYCN
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Marking Emerging β- and γδ-Selected T Cells
PTEN and p53: Who will get the upper hand?
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
Skp2, the FoxO1 hunter Cancer Cell
The Ribosome and TORC2: Collaborators for Cell Growth
Presentation transcript:

Turning Reciprocal Feedback Regulation into Combination Therapy Timothy C. Thompson  Cancer Cell  Volume 19, Issue 6, Pages 697-699 (June 2011) DOI: 10.1016/j.ccr.2011.05.022 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Reciprocal Inhibition Feedback Links AR- and PTEN Loss/PI3K-AKT Signaling Pathways in Prostate Cancer As reported in Carver et al. (2011) and Mulholland et al. (2011), reciprocal negative feedback underlies the oncogenic activities of PTEN loss/PI3K-AKT signaling (depicted as the area inside the dotted “corners”). Activation of PI3K-AKT leads to suppression/subversion of AR signaling through suppression of HER kinases; upregulation of EGR1 and c-JUN transcriptional coregulators; and upregulation of the Polycomb group protein EZH2. Reciprocal negative feedback is established, in part, through AR-stimulated, FKBP5-mediated activation of AKT phosphatase PHLPP. GFs, growth factors. Cancer Cell 2011 19, 697-699DOI: (10.1016/j.ccr.2011.05.022) Copyright © 2011 Elsevier Inc. Terms and Conditions